Chemoinformaics analysis of octadeca-2,9-dienoic-acid
Molecular Weight | 480.378 | nRot | 4 |
Heavy Atom Molecular Weight | 460.218 | nRig | 12 |
Exact Molecular Weight | 480.09 | nRing | 4 |
Solubility: LogS | -4.033 | nHRing | 2 |
Solubility: LogP | 3.658 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
nHetero | 13 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 13 | No. of Arom Bond | 17 |
nHA | 13 | APOL | 58.8319 |
nHD | 9 | BPOL | 26.1401 |
QED | 0.704 |
Synth | 4.129 |
Natural Product Likeliness | 2.912 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.008 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.516 |
MDCK | 0.000013 |
BBB | 0.864 |
PPB | 0.903159 |
VDSS | 2.719 |
FU | 0.0325327 |
CYP1A2-inh | 0.167 |
CYP1A2-sub | 0.516 |
CYP2c19-inh | 0.038 |
CYP2c19-sub | 0.6 |
CYP2c9-inh | 0.082 |
CYP2c9-sub | 0.611 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.883 |
CYP3a4-inh | 0.232 |
CYP3a4-sub | 0.4 |
CL | 11.09 |
T12 | 0.205 |
hERG | 0.027 |
Ames | 0.013 |
ROA | 0.018 |
SkinSen | 0.071 |
Carcinogencity | 0.729 |
EI | 0.592 |
Respiratory | 0.845 |
NR-Aromatase | 0.005 |
Antiviral | Yes |
Prediction | 0.86646 |